Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use–Associated Infective Endocarditis

Authors:

Abstract
Hospitalizations associated with infective endocarditis in the US increased from 16 per 100 000 adults in 2003 to 22 per 100 000 adults in 2016.1 Injection drug use–associated infective endocarditis (IDU-IE) currently accounts for 1 in 10 hospitalizations for infective endocarditis.2 This increase has largely been associated with the opioid epidemic, specifically the injection of heroin and fentanyl. If current patterns continue, more than 250 000 individuals in the US may die of IDU-IE between 2020 and 2030.3 There is a substantial need to define optimal treatment strategies given the increasing burden of IDU-IE in the US.

This publication has 63 references indexed in Scilit: